http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114848681-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4bd9f87ca6e95bd3d5659003acd7550
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
filingDate 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0ab7db476c03ee2da2bbf088fd2bf62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f81109d8f0a45b835cef6206c109e5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce5056c6a908885e3f591c86d65d99a7
publicationDate 2022-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114848681-A
titleOfInvention A kind of immunotherapy composition and use thereof
abstract An immunotherapy composition and use thereof, comprising: lipophilic muramyl dipeptide (MDP) analog-liposome-encapsulated muramyl tripeptide phosphatidylethanolamine, the immunotherapy composition containing mycobacterial cell wall components , is a natural immune stimulator, and its liposome preparation is easily taken up by macrophages in tissues (especially the lung), which is a common metastatic site of osteosarcoma. It has a variety of biological response regulating activities, which can stimulate the host defense mechanism and inhibit tumor metastasis; it can enhance the movement and migration of peripheral lymphocytes and tumor-infiltrating lymphocytes in cancer patients, and can cause damaged tumor-infiltrating lymphocytes in melanoma patients. The ability of cell movement and migration is restored.
priorityDate 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493308
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID854836
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8WML4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3690
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21926
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403922
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ60528
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451714
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ02496
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ29435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11672602
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426327438

Total number of triples: 39.